Positive correlation of steroid hormones and EGF in canine mammary cancer

Journal of Steroid Biochemistry and Molecular Biology

Volumn 115, Issue 1-2, 2009, Pages 9-13

  Queiroga, Felisbina L ^a   Pérez Alenza, Dolores ^b   Silvan, Gema ^b   Peña, Laura ^b   Illera, Juan C ^b  

^a UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Androstenedione; Canine mammary tumours; Dehydroepiandrosterone; Epidermal growth factor; Estradiol; Inflammatory mammary carcinoma; Progesterone

Indexed keywords

ANDROSTENEDIONE; EPIDERMAL GROWTH FACTOR; ESTRADIOL; PRASTERONE; PROGESTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOMA; BREAST DYSPLASIA; BREAST TUMOR; CONTROLLED STUDY; DOG; ENZYME IMMUNOASSAY; FEMALE; HISTOPATHOLOGY; HORMONE DETERMINATION; MAMMARY GLAND; NONHUMAN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SYMPTOMATOLOGY; TISSUE LEVEL;

ANDROSTENEDIONE; ANIMALS; DEHYDROEPIANDROSTERONE; DOGS; EPIDERMAL GROWTH FACTOR; ESTRADIOL; MAMMARY NEOPLASMS, ANIMAL; PROGESTERONE; RECEPTOR CROSS-TALK; STEROIDS;

CANIS FAMILIARIS;

EID: 67349221486     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2009.01.018     Document Type: Article

References (43)

1. Perez Alenza M.D., Peña L., del Castillo N., and Nieto A.I. Factors influencing the incidence and prognosis of canine mammary tumours. J. Small Anim. Pract. 41 (2000) 287-291
2. Sorenmo K.U., Shofer F.S., and Goldschmidt M.H. Effect of spaying and timing of spaying on survival of dogs with mammary carcinoma. J. Vet. Intern. Med. 14 (2000) 266-270
3. Alves A., Prada J., Almeida J.M., Pires I., Queiroga F., Platt S.R., and Varejão A.S. Primary and secondary tumours occurring simultaneously in the brain of a dog. J. Small Anim. Pract. 47 (2006) 607-610
4. Pérez-Alenza M.D., Tabanera E., and Pena L. Inflammatory mammary carcinoma in dogs: 33 cases (1995-1999). J. Am. Vet. Med. Assoc. 219 (2001) 1110-1114
5. Pena L., Pérez-Alenza M.D., Rodriguez-Bertos A., and Nieto A. Canine inflammatory mammary carcinoma: histopathology, immunohistochemistry and clinical implications of 21 cases. Breast Cancer Res. Treat. 78 (2003) 141-148
6. Queiroga F.L., Perez-Alenza M.D., Silvan G., Pena L., Lopes C., and Illera J.C. Cox-2 levels in canine mammary tumors, including inflammatory mammary carcinoma: clinicopathological features and prognostic significance. Anticancer Res. 25 (2005) 4269-4275
7. Giordano S.H. Update on locally advanced breast cancer. Oncologist 8 (2003) 521-530
8. Pena L., Silvan G., Perez-Alenza M.D., and Illera J.C. Steroid hormone profile of canine inflammatory mammary carcinoma: a preliminary study. J. Steroid Biochem. Mol. Biol. 84 (2003) 211-216
9. Illera J.C., Perez-Alenza M.D., Nieto A., Jimenez M.A., Silvan G., Dunner S., and Pena L. Steroids and receptors in canine mammary cancer. Steroids 71 (2006) 541-548
10. Artagaveytia N., Le Penven S., Falette N., Lucero R., Garófalo E.G., and Saez S. Epidermal growth factor and transforming growth factor alpha mRNA expression in human breast cancer biopsies; analysis in relation to estradiol, progesterone and EGF receptor content. J. Steroid Biochem. Mol. Biol. 60 (1997) 221-228
11. Queiroga F.L., Perez-Alenza M.D., Silvan G., Pena L., Lopes C., and Illera J.C. Crosstalk between GH/IGF-I axis and steroid hormones (progesterone, 17beta-estradiol) in canine mammary tumours. J. Steroid Biochem. Mol. Biol. 110 (2008) 76-82
12. Ignar-Trowbridge D.M., Nelson K.G., Bidwell M.C., Curtis S.W., Washburn T.F., McLachlan J.A., and Korach K.S. Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 4658-4662
13. Banerjee S., Sengupta K., Saxena N.K., Dhar K., and Banerjee S.K. Epidermal growth factor induces WISP-2/CCN5 expression in estrogen receptor-alpha-positive breast tumor cells through multiple molecular cross-talks. Mol. Cancer Res. 3 (2005) 151-162
14. Treeck O., Weber A., Boester M., Porz S., Frey N., Diedrich K., and Ortmann O. H-ras dependent estrogenic effects of epidermal growth factor in the estrogen-independent breast cancer cell line MDA-MB-231. Breast Cancer Res. Treat. 80 (2003) 155-162
15. Richer J.K., Lange C.A., Manning N.G., Owen G., Powell R., and Horwitz K.B. Convergence of progesterone with growth factor and cytokine signaling in breast cancer. Progesterone receptors regulate signal transducers and activators of transcription expression and activity. J. Biol. Chem. 273 (1998) 31317-31326
16. Migliaccio A., Di Domenico M., Castoria G., Nanayakkara M., Lombardi M., de Falco A., Bilancio A., Varricchio L., Ciociola A., and Auricchio F. Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action. Cancer Res. 65 (2005) 10585-10593
17. Hitosugi T., Sasaki K., Sato M., Suzuki Y., and Umezawa Y. Epidermal growth factor directs sex-specific steroid signaling through Src activation. J. Biol. Chem. 282 (2007) 10697-10706
18. Rutteman G.R., and Misdorp W. Hormonal background of canine and feline mammary tumours. J. Reprod. Fertil. 47 (1993) 483-487
19. Queiroga F.L., Perez-Alenza M.D., Silvan G., Pena L., Lopes C., and Illera J.C. Role of steroid hormones and prolactin in canine mammary cancer. J. Steroid Biochem. Mol. Biol. 94 (2005) 181-187
20. L.N. Owen, TMN Classification of Tumors in Domestic Animals, ED, VPH/CMO/80.20, World Health Organizaton, Geneva, 1980.
21. Misdorp W., Else R.W., Hellmen E., and Lipscomb T.P. Histological Classification of Mammary Tumors of the Dog and Cat. Second Series vol. 7 (1999), Armed Forces Institute of Pathology and World Health Organization, Washington
22. Ketcham A.S., and Sindelar W.F. Risk factors in breast cancer. Prog. Clin. Cancer 6 (1975) 99-114
23. Labrie F., Luu-The V., Labrie C., Bélanger A., Simard J., Lin S.X., and Pelletier G. Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocr. Rev. 24 (2003) 152-182
24. Schneider R., Dorn C.R., and Taylor D.O.N. Factores influencing canine mammary cancer development and postsurgical survival. J. Natl. Cancer Inst. 43 (1969) 1249-1261
25. van Golen K.L., Bao L.W., Pan Q., Miller F.R., Wu Z.F., and Merajver S.D. Mitogen activated protein kinase pathway is involved in RhoC GTPase induced motility, invasion and angiogenesis in inflammatory breast cancer. Clin. Exp. Metastasis 19 (2002) 301-311
26. Mosadegh B., Saadi W., Wang S.J., and Jeon N.L. Epidermal growth factor promotes breast cancer cell chemotaxis in CXCL12 gradients. Biotechnol. Bioeng. 100 (2008) 1205-1213
27. Balkwill F. Cancer and the chemokine network. Nat. Rev. Cancer 4 (2004) 540-550
28. Rutteman G.R. Hormones and mammary tumour disease in the female dog: an update. In Vivo 4 (1990) 33-40
29. Geraldes M., Gärtner F., and Schmitt F. Immunohistochemical study of hormonal receptors and cell proliferation in normal canine mammary glands and spontaneous mammary tumours. Vet. Rec. 14 (2000) 403-406
30. de Las Mulas J.M., Millán Y., and Dios R. A prospective analysis of immunohistochemically determined estrogen receptor alpha and progesterone receptor expression and host and tumor factors as predictors of disease-free period in mammary tumors of the dog. Vet. Pathol. 42 (2005) 200-212
31. Nieto A., Peña L., Pérez-Alenza M.D., Sánchez M.A., Flores J.M., and Castaño M. Immunohistologic detection of estrogen receptor alpha in canine mammary tumors: clinical and pathologic associations and prognostic significance. Vet. Pathol. 37 (2000) 239-247
32. Donnay I., Rauïs J., Wouters-Ballman P., Devleeschouwer N., Leclercq G., and Verstegen J.P. Receptors for oestrogen, progesterone and epidermal growth factor in normal and tumorous canine mammary tissues. Am. J. Vet. Res. 56 (1995) 1188-1194
33. Gehm B.D., McAndrews J.M., Jordan V.C., and Jameson J.L. EGF activates highly selective estrogen-responsive reporter plasmids by an ER-independent pathway. Mol. Cell. Endocrinol. 159 (2000) 53-62
34. Albanito L., Sisci D., Aquila S., Brunelli E., Vivacqua A., Madeo A., Lappano R., Pandey D.P., Picard D., Mauro L., Andò S., and Maggiolini M. Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells. Endocrinology 149 (2008) 3799-3808
35. Hoffmann J., and Sommer A. Steroid hormone receptors as targets for the therapy of breast and prostate cancer-recent advances, mechanisms of resistance, and new approaches. J. Steroid Biochem. Mol. Biol. 93 (2005) 191-200
36. Conneely O.M., Mulac-Jericevic B., and Arnett-Mansfield R. Progesterone signaling in mammary gland development. Ernst Schering Found. Symp. Proc. 1 (2007) 45-54
37. Lange C.A. Making sense of cross-talk between steroid hormone receptors and intracellular signaling pathways: who will have the last word?. Mol. Endocrinol. 18 (2004) 269-278
38. Daniel A.R., Qiu M., Faivre E.J., Ostrander J.H., Skildum A., and Lange C.A. Linkage of progestin and epidermal growth factor signaling: phosphorylation of progesterone receptors mediates transcriptional hypersensitivity and increased ligand-independent breast cancer cell growth. Steroids 72 (2007) 188-201
39. Carvajal A., Espinoza N., Kato S., Pinto M., Sadarangani A., Monso C., Aranda E., Villalon M., Richer J.K., Horwitz K.B., Brosens J.J., and Owen G.I. Progesterone pre-treatment potentiates EGF pathway signaling in the breast cancer cell line ZR-75. Breast Cancer Res. Treat. 94 (2005) 171-183
40. Groshong S.D., Owen G.I., Grimison B., Schauer I.E., Todd M.C., Langan T.A., Sclafani R.A., Lange C.A., and Horwitz K.B. Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27 (Kip1). Mol. Endocrinol. 11 (1997) 1593-1607
41. Lange C.A., Richer J.K., Shen T., and Horwitz K.B. Convergence of progesterone and epidermal growth factor signaling in breast cancer. Potentiation of mitogen-activated protein kinase pathways. J. Biol. Chem. 273 (1998) 31308-31316
42. Auricchio F., Migliaccio A., and Castoria G. Sex-steroid hormones and EGF signalling in breast and prostate cancer cells: targeting the association of Src with steroid receptors. Steroids 73 (2008) 880-884
43. Hackel P.O., Zwick E., Prenzel N., and Ullrich A. Epidermal growth factor receptors: critical mediators of multiple receptor pathways. Curr. Opin. Cell Biol. 11 (1999) 184-189